Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin.
Ferrannini G, Gerstein H, Colhoun HM, Dagenais GR, Diaz R, Dyal L, Lakshmanan M, Mellbin L, Probstfield J, Riddle MC, Shaw JE, Avezum A, Basile JN, Cushman WC, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Pais P, Pīrāgs V, Pogosova N, Raubenheimer PJ, Sheu WH, Rydén L.
Ferrannini G, et al. Among authors: dagenais gr.
Eur Heart J. 2021 Jul 8;42(26):2565-2573. doi: 10.1093/eurheartj/ehaa777.
Eur Heart J. 2021.
PMID: 33197271
Clinical Trial.